Highly Efficient and Tumor-Restricted Gene Transfer to Malignant Gliomas by Replication-Competent Retroviral Vectors

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Human Gene Therapy

• Publication date

  2003-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/104303403321070810PMID 12614563PMCID PMC8295717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective Transduction of Malignant Glioma by Lentiviral Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoproteins

  2004cited by this paper
• Tissue-specific promoters for cancer gene therapy

  2004cited by this paper
• Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.

  2002cited by this paper
• Gene Therapy a Suspect in Leukemia-like Disease

  2002cited by this paper
• Genomic Stability of Murine Leukemia Viruses Containing Insertions at the Env-3′ Untranslated Region Boundary

  2001cited by this paper
• Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.

  2001cited by this paper
• A Uniquely Stable Replication-Competent Retrovirus Vector Achieves Efficient Gene Delivery in Vitro and in Solid Tumors

  2001cited by this paper
• Preclinical Safety Evaluation of G207, a Replication-Competent Herpes Simplex Virus Type 1, Inoculated Intraprostatically in Mice and Nonhuman Primates

  2001cited by this paper
• Preexisting Immunity to Poliovirus Does Not Impair the Efficacy of Recombinant Poliovirus Vaccine Vectors

  2001cited by this paper
• A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme

  2000cited by this paper
• Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials

  1999cited by this paper
• Cisplatin Resistant Glioblastoma Cells may have Increased Concentration of Urokinase Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

  1999cited by this paper
• Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein.

  1998cited by this paper
• Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.

  1998cited by this paper
• The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.

  1998cited by this paper
• Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.

  1997cited by this paper
• Establishment of Parameters for Optimal Transduction Efficiency and Antitumor Effects with Purified High-Titer HSV-TK Retroviral Vector in Established Solid Tumors

  1997cited by this paper
• Murine leukemia virus-based Tat-inducible long terminal repeat replacement vectors: a new system for anti-human immunodeficiency virus gene therapy

  1996cited by this paper
• Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.

  1996cited by this paper
• A replication-competent promoter-trap retrovirus

  1996cited by this paper
• In vivo radiation sensitivity of glioblastoma multiforme.

  1995cited by this paper
• Tissue-specific targeting of retroviral vectors through ligand-receptor interactions.

  1994cited by this paper
• Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors

  1994cited by this paper
• High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector

  1993cited by this paper
• Retroviral vectors displaying functional antibody fragments.

  1993cited by this paper
• Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

  1992cited by this paper
• Experimental therapy of human glioma by means of a genetically engineered virus mutant

  1991influential reference
• No Retroviremia or Pathology in Long-Term Follow-Up of Monkeys Exposed to a Murine Amphotropic Retrovirus

  1991cited by this paper
• Amphotropic Murine Leukemia Retrovirus Is Not an Acute Pathogen for Primates

  1990cited by this paper
• Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance

  1989influential reference
• Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

  1987cited by this paper
• Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences.

  1985cited by this paper

• Small Particles, Big Impact: Inorganic Nanotechnology for Glioblastoma

  2026cites this paper
• Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects.

  2025cites this paper
• Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities

  2025influential citation
• The Use of Personalized Medicine in Pancreatic Ductal Adenocarcinoma (PDAC): New Therapeutic Opportunities

  2024cites this paper
• Targeted Suicide Gene Therapy with Retroviral Replicating Vectors for Experimental Canine Cancers

  2024cites this paper
• Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?

  2023cites this paper
• Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer

  2023cites this paper
• Engineering Non-Human RNA Viruses for Cancer Therapy

  2023cites this paper
• Optimal delivery of RNA interference by viral vectors for cancer therapy.

  2023cites this paper
• Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer

  2022cites this paper
• Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model

  2022cites this paper
• Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer

  2021cites this paper
• Efficient prodrug activator gene therapy by retroviral 2 replicating vectors prolongs survival in an immune- 3 competent intracerebral glioma model 4

  2020cites this paper
• Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model

  2020cites this paper
• Recent progress in the research of suicide gene therapy for malignant glioma

  2019cites this paper
• Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.

  2019cites this paper
• Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models

  2019cites this paper
• Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer

  2018cites this paper
• Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors

  2018cites this paper
• Chapter 7 Replicating Retroviral Vectors for Gene Therapy of Solid Tumors

  2018influential citation
• Dual-vector prodrug activator gene therapy using retroviral replicating vectors

  2018cites this paper
• Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity

  2017cites this paper
• A Sophism in Vectorology: Turning Harmful Defective Retroviral Vectors into Helpful Replication-Competent Retroviruses Against Cancer

  2017cites this paper
• Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma

  2016cites this paper
• Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene

  2016cites this paper
• Viral Oncolysis of Glioblastoma

  2016cites this paper
• Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types

  2015cites this paper
• Intravenous Administration of Retroviral Replicating Vector, Toca 511, Demonstrates Therapeutic Efficacy in Orthotopic Immune-Competent Mouse Glioma Model

  2015cites this paper
• Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types

  2015cites this paper
• Chronic inflammation drives glioma growth: cellular and molecular factors responsible for an immunosuppressive microenvironment

  2014cites this paper
• Radio-sensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector

  2014cites this paper
• Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors

  2014cites this paper
• Enhancing the Safety and Efficiency of Retroviral Replicating Vectors for Cancer Gene Therapy

  2014cites this paper
• Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus

  2013cites this paper
• Combined Alloreactive CTL Cellular Therapy with Prodrug Activator Gene Therapy in a Model of Breast Cancer Metastatic to the Brain

  2013cites this paper
• Replicating Retroviral Vectors for Gene Therapy of Solid Tumors

  2013influential citation
• Tissue-and Tumour-Selective Targeting of Murine Leukemia Virus-Based Replication-Competent Retroviral Vectors

  2012cites this paper
• Retroviral replicating vectors in cancer.

  2012cites this paper
• Replicating retroviral vectors for oncolytic virotherapy of experimental hepatocellular carcinoma.

  2012cites this paper
• Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression.

  2012cites this paper
• Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma

  2011cites this paper
• RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors

  2011cites this paper
• Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma

  2011influential citation
• Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.

  2011cites this paper
• Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene

  2010cites this paper
• Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma.

  2010cites this paper
• Bmc Molecular Biology Influence of Vector Design and Host Cell on the Mechanism of Recombination and Emergence of Mutant Subpopulations of Replicating Retroviral Vectors

  2009cites this paper
• Remission of Invasive, Cancer Stem-Like Glioblastoma Xenografts Using Lentiviral Vector-Mediated Suicide Gene Therapy

  2009cites this paper
• Emerging Treatment Modalities II: Gene Therapy for Meningiomas

  2009cites this paper
• The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer.

  2009cites this paper
• Gene therapy as an adjuvant treatment for malignant gliomas: from bench to bedside

  2009influential citation
• Replication-competent retrovirus vectors for cancer gene therapy.

  2008cites this paper
• Neural stem cell-mediated enhanced gene therapy of malignant gliomas using a novel plant thymidine kinase

  2008cites this paper
• Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue

  2008cites this paper
• Environmental risk assessment of replication competent viral vectors in gene therapy trials

  2008cites this paper
• Conventional and gene therapy strategies for the treatment of brain tumors.

  2008cites this paper
• Preventing growth of brain tumors by creating a zone of resistance.

  2008cites this paper
• Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model.

  2007cites this paper
• An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.

  2007cites this paper
• Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.

  2007cites this paper
• International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China

  2007cites this paper
• Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

  2007cites this paper
• Colorectal Cancer Metastasis Model Mediated Suicide Gene Therapy in a Multifocal − Vector Therapeutic Efficacy of Replication-Competent Retrovirus

  2007cites this paper
• Effects of Viral Strain, Transgene Position, and Target Cell Type on Replication Kinetics, Genomic Stability, and Transgene Expression of Replication-Competent Murine Leukemia Virus-Based Vectors

  2007cites this paper
• Highly Efficient Gene Delivery for Bladder Cancers by Intravesically Administered Replication-Competent Retroviral Vectors

  2007cites this paper
• Normal Brain Cells Contribute to the Bystander Effect in Suicide Gene Therapy of Malignant Glioma

  2007cites this paper
• Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts

  2007cites this paper
• Prodrug Approaches for Drug Delivery to the Brain

  2007cites this paper
• Lentiviral and Retroviral Vector Systems

  2007influential citation
• Genetic strategies for brain tumor therapy

  2006cites this paper
• Tumor-Selective Gene Expression in a Hepatic Metastasis Model after Locoregional Delivery of a Replication-Competent Retrovirus Vector

  2006cites this paper
• VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment

  2006cites this paper
• Tissue- and Tumor-Specific Targeting of Murine Leukemia Virus-Based Replication-Competent Retroviral Vectors

  2006cites this paper
• Viral vectors for gene-directed enzyme prodrug therapy.

  2006cites this paper
• From leading role to the backstage: mesenchymal stem cells as packaging cell lines for in situ production of viral vectors.

  2006cites this paper
• Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.

  2006cites this paper
• Oncolytic adenoviral therapy for glioblastoma multiforme.

  2006cites this paper
• Gene therapy for gastric cancer: is it promising?

  2006cites this paper
• Entwicklung hepatotroper Gentransfer-Systeme auf Basis des Felinen Immundefizienz Virus (FIV) und des Moloney Maus Leukämie Virus (MoMLV) pseudotypisiert mit dem Fusionshüllglykoprotein des Sendai Virus (SeV)

  2006cites this paper
• Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.

  2005cites this paper
• Combined Liposome-Mediated Cytosine Deaminase Gene Therapy with Radiation in Killing Rectal Cancer Cells and Xenografts in Athymic Mice

  2005cites this paper
• Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.

  2005influential citation
• Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• Chapter 14 – Gene Therapy for Malignant Gliomas

  2005cites this paper
• Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells

  2005cites this paper
• Gene therapy and targeted toxins for glioma.

  2005cites this paper
• Viral vectors as therapeutic agents for glioblastoma.

  2005cites this paper
• Murine leukemia virus (MLV) replication monitored with fluorescent proteins

  2004cites this paper
• Selective Transduction of Malignant Glioma by Lentiviral Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoproteins

  2004cites this paper
• Glial-specific retrovirally mediated gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo.

  2004cites this paper
• Tissue-specific promoters for cancer gene therapy

  2004cites this paper
• Gene therapy of gliomas.

  2003cites this paper
• Comparison of replication-selective, oncolytic viruses for the treatment of human cancers.

  2003cites this paper
• Local Therapies for Glioma Present Status and Future Developments

  2003cites this paper
• ARROW@TU Dublin ARROW@TU Dublin

  year unknowncites this paper